The agency remains “deeply troubled by the role drug manufacturers like Eli Lilly, Novo Nordisk, and Sanofi play in driving up list prices of life-saving medications like insulin.” If we examine how rebates work, we can see the interplay between PBMs and pharmaceutical manufacturers. It’s ...